Cargando…
Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
The implantable cardioverter-defibrillator (ICD) has become an integral part of treatment for a variety of patients with symptomatic, or at risk for, ventricular tachyarrhythmias. The ICD's effectiveness is attributed to its ability to promptly detect and terminate ventricular tachycardia (VT)...
Autor principal: | Pires, Luis A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Indian Heart Rhythm Society
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939869/ https://www.ncbi.nlm.nih.gov/pubmed/17684575 |
Ejemplares similares
-
Implantable cardioverter-defibrillators /
Publicado: (1994) -
Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
por: van der Stuijt, W., et al.
Publicado: (2020) -
Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015) -
Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018) -
Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)